News Focus
News Focus
Followers 5
Posts 487
Boards Moderated 0
Alias Born 10/15/2013

Re: Whosetosay post# 57493

Thursday, 12/18/2014 5:30:54 PM

Thursday, December 18, 2014 5:30:54 PM

Post# of 80490
Of course he did... after the FDA's action.
And he also continues to support ponatinib use and clinical studies to identify its usefulness in less heavily pretreated populations. Meaning first and second line use. I guess he is still a strong ponatinib booster because of his concerns...

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today